Builders Firstsource buy BiotechBee
Start price
03.09.23
/
70%
€138.35
Target price
30.11.25
€200.00
Performance (%)
-5.49%
End price
02.12.23
€130.75
Summary
This prediction ended on 02.12.23 with a price of €130.75. With a performance of -5.49%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Builders Firstsource | -1.075% | -1.075% | -37.570% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
According to BiotechBee what are the pros and cons of Builders Firstsource for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Builders Firstsource diskutieren
Buy mit Kursziel 200,0